June 2016

Chairman's Letter
Chairman’s Letter
Michael J. Hennessy
From the Editor
From the Editor
Metastatic Breast Cancer
Assessing Treatment Response in Metastatic Breast Cancer
Shlomit Strulov Shachar, MD, and Hyman B. Muss, MD
Male Breast Cancer
Case Report: Male Breast Cancer
Lucy R Khan, BSc (Hons) MB ChB MRCSEd and J. Michael Dixon, BSc (Hons) MB ChB MD FRCS FRCSEd FRCPEd OBE
High-Risk Follicular Lymphoma
How to Refine Treatment Choice in Follicular Lymphoma: From Low-Tumor Burden to High-Risk Follicular Lymphoma
Peter A. Riedell, MD and Brad S. Kahl, MD
Refractory Immune Thrombocytopenia
Complement Blockade with C1 Esterase Inhibitor in Refractory Immune Thrombocytopenia
Erin Roesch, MD, and Catherine Broome, MD
CME/CE Breast Cancer
Recent Developments in the Treatment of HER2-Positive Breast Cancer